Article

22q11 gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.

GW Institute for Neuroscience and Department of Pharmacology and Physiology, The George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Human Molecular Genetics (Impact Factor: 6.68). 10/2012; DOI: 10.1093/hmg/dds429
Source: PubMed

ABSTRACT We asked whether key morphogenetic signaling pathways interact with 22q11 gene dosage to modulate the severity of cranial or cardiac anomalies in DiGeorge/22q1Deletion Syndrome (22q11DS). Sonic hedgehog (Shh) and Retinoic Acid (RA) signaling is altered in the brain and heart-clinically significant 22q11DS phenotypic sites-in LgDel mouse embryos, an established 22q11DS model. LgDel embryos treated with cyclopamine, a Shh inhibitor, or carrying mutations in Gli3(Xtj), a Shh signaling effector, have morphogenetic anomalies that are either not seen, or seen at significantly lower frequencies in control or single mutant embryos. Similarly, RA exposure or genetic loss of RA function via heterozygous mutation of the RA synthetic enzyme Raldh2 induces novel cranial anomalies and enhances cardiovascular phenotypes in LgDel but not other genotypes. These changes are not seen in heterozygous Tbx1 mutant embryos-a 22q11 gene thought to explain much of 22q11DS pathogenesis-in which Shh or RA signaling has been similarly modified. Our results suggest that full dosage of 22q11 genes beyond Tbx1 establish an adaptive range for morphogenetic signaling via Shh and RA. When this adaptive range is constricted by diminished dosage of 22q11 genes, embryos are sensitized to otherwise benign changes in Shh and RA signaling. Such sensitization, in the face of environmental or genetic factors that modify Shh or RA signaling, may explain variability in 22q11DS morphogenetic phenotypes.

0 Followers
 · 
118 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inhibitory local circuit neurons (LCNs), often called interneurons, play vital roles in the development and function of cortical networks. Their inhibitory influences regulate both the excitability of cortical projection neurons on the level of individual cells, and the synchronous activity of projection neuron ensembles that appear to be a neural basis for major aspects of cognitive processing. Dysfunction of LCNs has been associated with neurological and psychiatric diseases such as epilepsy, schizophrenia and autism. Here we review progress in understanding LCN fate determination, their non-radial migration to the cortex, their maturation within the cortex, and the contribution of LCN dysfunction to neuropsychiatric disorders.Neuropsychopharmacology Reviews accepted article peview online, 8 August 2014. doi:10.1038/npp.2014.171.
    Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 08/2014; DOI:10.1038/npp.2014.171 · 8.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The placenta plays a critical role in the survival and growth of the fetus. Here we demonstrate that the HECT (Homologous to the E6-AP Carboxyl Terminus) domain E3 ubiquitin ligase, Hectd1, is essential for development of the mouse placenta. Hectd1 is widely expressed during placentation with enrichment in trophoblast giant cells (TGCs) and other trophoblast-derived cell subtypes in the junctional and labyrinth zones of the placenta. Disruption of Hectd1 results in lethality at mid-gestation associated with intrauterine growth restriction (IUGR). Variable defects in the gross structure of the mutant placenta are found including alterations in diameter, thickness and lamination. The number and nuclear size of trophoblast giant cells (TGC) is reduced. Examination of subtype specific markers reveals altered TGC development with decreased expression of Placental lactogen-1 (Pl1) and Placental lactogen-1 (Pl2) and increased expression of Proliferin (Plf). In addition, Cathepsin Q (Ctsq) positive sinusoidal TGCs were mislocalized. Reduced numbers of spongiotrophoblasts and glycogen trophoblasts were also found at the junctional zone of the Hectd1 mutant placenta. Finally, the number of uterine natural killer cells in the maternal decidua is increased but the size of these cells is reduced. The numbers of cells undergoing apoptosis is increased in the mutant placenta. Proliferation is differentially altered in the layers of the placenta with an increase in the maternal decidua, decreased in the labyrinth layer and unchanged in the junctional zone. Thus, Hectd1 is required for development of multiple lineages that comprise the placenta and mutation of Hectd1 results in abnormal development of this vital organ.
    Developmental Biology 05/2014; 392(2). DOI:10.1016/j.ydbio.2014.05.007 · 3.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We assessed feeding-related developmental anomalies in the LgDel mouse model of Chromosome 22q11 Deletion Syndrome (22q11DS), a common developmental disorder that frequently includes perinatal dysphagia - debilitating feeding, swallowing and nutrition difficulties from birth onward - within its phenotypic spectrum. LgDel pups gain significantly less weight during the first postnatal weeks, and have several signs of respiratory infections due to food aspiration. Most 22q11 genes are expressed in anlagen of craniofacial and brainstem regions critical for feeding and swallowing, and diminished expression in LgDel embryos apparently compromises development of these regions. Palate and jaw anomalies indicate divergent oro-facial morphogenesis. Altered expression and patterning of hindbrain transcriptional regulators, especially those related to retinoic acid (RA) signaling prefigures these disruptions. Subsequently, gene expression, axon growth and sensory ganglion formation in the trigeminal (V), glossopharyngeal (IX), or vagus (X) cranial nerves (CN) that innervate targets essential for feeding, swallowing and digestion are disrupted. Posterior CN IX and X ganglia anomalies primarily reflect diminished dosage of the 22q11DS candidate gene Tbx1. Genetic modification of RA signaling in LgDel embryos rescues the anterior CN V phenotype and returns expression levels or pattern of RA-sensitive genes to that in wild type embryos. Thus, diminished 22q11 gene dosage, including but not limited to Tbx1, disrupts oro-facial and cranial nerve development by modifying RA-modulated anterior-posterior hindbrain differentiation. These disruptions likely contribute to dysphagia in infants and young children with 22q11DS.
    Disease Models and Mechanisms 12/2013; DOI:10.1242/dmm.012484 · 5.54 Impact Factor